CIK 0001443863 · Non-accelerated filer<br>Smaller reporting company
BioCorRx Inc.
Sign in to watch- Ticker
- BICX
- Exchange
- OTC
- Industry
- Services-Specialty Outpatient Facilities, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 900967447
- Phone
- (714) 462-4880
- Business address
- 2390 EAST ORANGEWOOD AVENUE, SUITE 570, ANAHEIM, CA, 92806
- Former names
- FRESH START PRIVATE MANAGEMENT, INC., Cetrone Energy CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-29 | GALLIGAN JOSEPH J Director | Purchase | +171,296 | $1.75 | $300K | 217,546 |
| 2023-01-30 | Lucido Louis C. Director | Purchase | +300 | $1.39 | $417 | 102,059 |
| 2023-01-30 | Lucido Louis C. Director | Purchase | +100 | $1.37 | $137 | 102,159 |
| 2023-01-26 | Lucido Louis C. Director | Purchase | +500 | $1.29 | $647 | 101,759 |
| 2023-01-24 | Lucido Louis C. Director | Purchase | +200 | $1.20 | $240 | 101,259 |
| 2023-01-13 | Lucido Louis C. Director | Purchase | +2,000 | $1.10 | $2K | 99,059 |
| 2023-01-13 | Lucido Louis C. Director | Purchase | +2,000 | $1.15 | $2K | 101,059 |
| 2023-01-03 | Lucido Louis C. Director | Purchase | +2,000 | $1.10 | $2K | 97,059 |
| 2022-12-30 | GALLIGAN JOSEPH J Director | Grant or award | +5,319 | 46,250 | ||
| 2022-12-30 | Ingargiola Luisa Director | Grant or award | +5,319 | 33,675 | ||
| 2022-12-30 | Emry Kent Director | Grant or award | +5,319 | 105,492 | ||
| 2022-12-30 | Granier Brady James President | Grant or award · Stock Option | +15,957 | 15,957 | ||
| 2022-12-30 | Lucido Louis C. Director | Purchase | +200 | $0.98 | $195 | 89,625 |
| 2022-12-30 | Lucido Louis C. Director | Purchase | +115 | $1.03 | $118 | 89,740 |
| 2022-12-30 | Lucido Louis C. Director | Grant or award | +5,319 | 95,059 | ||
| 2022-12-30 | Felix Lourdes CEO and CFO | Grant or award | +5,319 | 60,083 | ||
| 2022-12-12 | Lucido Louis C. Director | Purchase | +1,000 | $0.79 | $790 | 85,425 |
| 2022-12-12 | Lucido Louis C. Director | Purchase | +1,000 | $0.98 | $980 | 86,425 |
| 2022-12-12 | Lucido Louis C. Director | Purchase | +1,000 | $0.80 | $800 | 87,425 |
| 2022-12-12 | Lucido Louis C. Director | Purchase | +2,000 | $0.80 | $2K | 89,425 |
Page 4 of 8 · 149 trades